Research Dr. Slitt’s re2search interests focus on how 1) expression of drug transporters affects chemical (i.e. drug and environmental chemical) disposition and toxicity, 2) nutrition and intake of dietary antioxidants affects the expression of drug transporters, 3) liver disease (i.e. diabetes, cholestasis, and ethanol cirrohsis) affects transporter expression and chemical disposition, and 4) transporter expression affects cholesterol transport and susceptibility to gallstone formation. Education Postdoctoral Fellowship, University of Kansas Medical Center, 2000-2004 Ph.D., University of Connecticut, Pharmaceutical Sciences (Pharmacology and Toxicology), 2000 B.S., University of Connecticut, Molecular and Cellular Biology, 1995